David Nierengarten
Stock Analyst at Wedbush
(4.76)
# 649
Out of 5,119 analysts
601
Total ratings
46.7%
Success rate
14.1%
Average return
Main Sectors:
Stocks Rated by David Nierengarten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COAG Hemab Therapeutics Holdings | Reiterated: Buy | $64 | $49.02 | +30.56% | 5 | Nov 5, 2026 | |
| DMRA Damora Therapeutics | Reiterated: Buy | $40 | $23.70 | +68.78% | 8 | Nov 5, 2026 | |
| KURA Kura Oncology | Reiterated: Buy | $19 → $36 | $7.27 | +395.19% | 2 | Nov 5, 2026 | |
| NUVB Nuvation Bio | Reiterated: Buy | $11 | $4.16 | +164.42% | 30 | Nov 5, 2026 | |
| ODTX Odyssey Therapeutics | Reiterated: Buy | $30 | $19.23 | +56.01% | 4 | Nov 5, 2026 | |
| XNCR Xencor | Reiterated: Buy | $45 | $35.75 | +25.87% | 20 | Nov 5, 2026 | |
| ARDX Ardelyx | Reiterated: Buy | $16 → $8 | $2.88 | +177.78% | 7 | Nov 4, 2026 | |
| ARVN Arvinas | Reiterated: Hold | $12 | $6.41 | +87.21% | 1 | Nov 4, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $65 → $30 | $26.41 | +13.59% | 22 | Nov 4, 2026 | |
| SYRE Spyre Therapeutics | Reiterated: Buy | $123 → $120 | $103.86 | +15.54% | 15 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 | $49.60 | +53.23% | 1 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,130 | $927.21 | +21.87% | 63 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $9.62 | +523.70% | 18 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 → $110 | $78.91 | +39.40% | 23 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $15.82 | +121.24% | 2 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $14 | $4.62 | +203.03% | 5 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $15.07 | +211.88% | 1 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.84 | +1,209.52% | 17 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $46.94 | +49.13% | 21 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $140 → $118 | $85.73 | +37.64% | 7 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $31.65 | +73.80% | 23 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $13 | $11.35 | +14.54% | 16 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $1 | $0.188 | +431.91% | 7 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $28.26 | +59.24% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 → $99 | $93.86 | +5.48% | 23 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $20 | $13.28 | +50.60% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $165 | $102.86 | +60.41% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.04 | +1,125.49% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $46.45 | +61.46% | 33 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $45.04 | -28.95% | 2 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $4.15 | +454.22% | 5 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $8.82 | +126.76% | 22 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 69.00 | kr 39.46 | +74.86% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $75 → $35 | $15.43 | n/a | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $19.88 | n/a | 11 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $30 | $8.65 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $1.84 | n/a | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $18.71 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $4.11 | n/a | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $4.65 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $4 | $0.0549 | n/a | 23 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $2 | $20.64 | n/a | 5 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $48 → $16 | $86.03 | n/a | 8 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $17 | $9.81 | n/a | 6 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $32 | $2.33 | n/a | 11 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $10 | $0.0004 | n/a | 3 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $36 | $1.87 | n/a | 7 | Jun 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $602.38 | n/a | 1 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $13 | $7.97 | n/a | 2 | Apr 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.10 | n/a | 1 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $13 | $4.39 | n/a | 6 | Oct 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $0.000001 | n/a | 7 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.02 | n/a | 7 | Aug 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $29.87 | n/a | 3 | May 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $9 | $0.639 | n/a | 4 | Nov 17, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $114.41 | n/a | 3 | Mar 31, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $25.79 | n/a | 1 | Mar 22, 2013 |
Hemab Therapeutics Holdings
Nov 5, 2026
Reiterated: Buy
Price Target: $64
Current: $49.02
Upside: +30.56%
Damora Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $40
Current: $23.70
Upside: +68.78%
Kura Oncology
Nov 5, 2026
Reiterated: Buy
Price Target: $19 → $36
Current: $7.27
Upside: +395.19%
Nuvation Bio
Nov 5, 2026
Reiterated: Buy
Price Target: $11
Current: $4.16
Upside: +164.42%
Odyssey Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $30
Current: $19.23
Upside: +56.01%
Xencor
Nov 5, 2026
Reiterated: Buy
Price Target: $45
Current: $35.75
Upside: +25.87%
Ardelyx
Nov 4, 2026
Reiterated: Buy
Price Target: $16 → $8
Current: $2.88
Upside: +177.78%
Arvinas
Nov 4, 2026
Reiterated: Hold
Price Target: $12
Current: $6.41
Upside: +87.21%
Beam Therapeutics
Nov 4, 2026
Reiterated: Buy
Price Target: $65 → $30
Current: $26.41
Upside: +13.59%
Spyre Therapeutics
Nov 4, 2026
Reiterated: Buy
Price Target: $123 → $120
Current: $103.86
Upside: +15.54%
Nov 3, 2026
Reiterated: Buy
Price Target: $76
Current: $49.60
Upside: +53.23%
Oct 23, 2026
Reiterated: Buy
Price Target: $1,130
Current: $927.21
Upside: +21.87%
Oct 22, 2026
Reiterated: Buy
Price Target: $60
Current: $9.62
Upside: +523.70%
Oct 19, 2026
Reiterated: Buy
Price Target: $88 → $110
Current: $78.91
Upside: +39.40%
Oct 2, 2026
Reiterated: Buy
Price Target: $35
Current: $15.82
Upside: +121.24%
Oct 2, 2026
Reiterated: Buy
Price Target: $11 → $14
Current: $4.62
Upside: +203.03%
Oct 1, 2026
Reiterated: Buy
Price Target: $47
Current: $15.07
Upside: +211.88%
Sep 25, 2026
Reiterated: Buy
Price Target: $11
Current: $0.84
Upside: +1,209.52%
Sep 25, 2026
Reiterated: Buy
Price Target: $70
Current: $46.94
Upside: +49.13%
Sep 22, 2026
Reiterated: Hold
Price Target: $140 → $118
Current: $85.73
Upside: +37.64%
Sep 16, 2026
Reiterated: Buy
Price Target: $55
Current: $31.65
Upside: +73.80%
Sep 9, 2026
Reiterated: Hold
Price Target: $17 → $13
Current: $11.35
Upside: +14.54%
Sep 3, 2026
Downgraded: Hold
Price Target: $5 → $1
Current: $0.188
Upside: +431.91%
Aug 14, 2026
Reiterated: Buy
Price Target: $45
Current: $28.26
Upside: +59.24%
Jul 28, 2026
Reiterated: Buy
Price Target: $72 → $99
Current: $93.86
Upside: +5.48%
Jul 24, 2026
Reiterated: Hold
Price Target: $18 → $20
Current: $13.28
Upside: +50.60%
May 14, 2026
Reiterated: Buy
Price Target: $165
Current: $102.86
Upside: +60.41%
May 13, 2026
Reiterated: Buy
Price Target: $25
Current: $2.04
Upside: +1,125.49%
Mar 31, 2026
Reiterated: Buy
Price Target: $75
Current: $46.45
Upside: +61.46%
Mar 17, 2026
Reiterated: Buy
Price Target: $32
Current: $45.04
Upside: -28.95%
Mar 11, 2026
Reiterated: Buy
Price Target: $23
Current: $4.15
Upside: +454.22%
Feb 24, 2026
Reiterated: Buy
Price Target: $20
Current: $8.82
Upside: +126.76%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: kr 69.00
Current: kr 39.46
Upside: +74.86%
Oct 14, 2025
Reiterated: Hold
Price Target: $75 → $35
Current: $15.43
Upside: n/a
Jun 26, 2025
Reiterated: Hold
Price Target: $8
Current: $19.88
Upside: n/a
May 23, 2025
Reiterated: Buy
Price Target: $31 → $30
Current: $8.65
Upside: n/a
May 14, 2025
Reiterated: Hold
Price Target: $5
Current: $1.84
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $33
Current: $18.71
Upside: n/a
Aug 9, 2024
Reiterated: Hold
Price Target: $2
Current: $4.11
Upside: n/a
Apr 2, 2024
Initiated Coverage: Buy
Price Target: $12
Current: $4.65
Upside: n/a
Jul 26, 2023
Reiterated: Hold
Price Target: $9 → $4
Current: $0.0549
Upside: n/a
Jul 12, 2023
Downgraded: Hold
Price Target: $4 → $2
Current: $20.64
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: $48 → $16
Current: $86.03
Upside: n/a
Jan 25, 2023
Reiterated: Buy
Price Target: $19 → $17
Current: $9.81
Upside: n/a
Jun 16, 2021
Reiterated: Buy
Price Target: $34 → $32
Current: $2.33
Upside: n/a
Aug 7, 2020
Reiterated: Hold
Price Target: $9 → $10
Current: $0.0004
Upside: n/a
Jun 18, 2019
Reiterated: Buy
Price Target: $19 → $36
Current: $1.87
Upside: n/a
Aug 16, 2018
Reiterated: Buy
Price Target: $95
Current: $602.38
Upside: n/a
Apr 23, 2018
Reiterated: Hold
Price Target: $55 → $13
Current: $7.97
Upside: n/a
Nov 28, 2017
Initiated Coverage: Buy
Price Target: $20
Current: $1.10
Upside: n/a
Oct 24, 2016
Reiterated: Hold
Price Target: $10 → $13
Current: $4.39
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $1.5 → $1
Current: $0.000001
Upside: n/a
Aug 3, 2016
Reiterated: Hold
Price Target: $2
Current: $1.02
Upside: n/a
May 9, 2016
Reiterated: Hold
Price Target: $4 → $3
Current: $29.87
Upside: n/a
Nov 17, 2015
Reiterated: Buy
Price Target: $16 → $9
Current: $0.639
Upside: n/a
Mar 31, 2014
Reiterated: Sell
Price Target: n/a
Current: $114.41
Upside: n/a
Mar 22, 2013
Reiterated: Hold
Price Target: n/a
Current: $25.79
Upside: n/a